# Medivis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medivis

- Industry: Healthcare IT
- Headquarters: Brooklyn, US
- Website: www.medivis.com
- Total disclosed funding: $27M
- Latest round: Series A (Jun 13, 2023)
- Investors on record: 7

## About

Medivis, Inc. is a technology company focused on enhancing surgical visualization through innovative augmented reality solutions, aiming to improve surgical outcomes and efficiency for healthcare providers.Founded in 2016 and headquartered in Brooklyn, US, Medivis, Inc. develops advanced visualization technologies for surgical applications. The company has completed five notable deals, with its most recent funding round occurring on June 13, 2023. Medivis secured USD 20.00 mn in Series A funding, led by Thrive Capital, with participation from Coalition Operators, Initialized Capital, Mayo Clinic Ventures, and Thirty5 Ventures. The founders, Christopher Morley and Osamah Choudhry, are both instrumental in guiding the company's vision and growth, with Osamah Choudhry serving as the CEO.Medivis specializes in advanced surgical visualization solutions, primarily through its flagship product, SurgicalAR, which transforms complex 2D imaging data into high-fidelity 3D visualizations. The company also offers FDA-cleared Spine Navigation solutions for open and minimally invasive surgeries, while developing Cranial Navigation and Prostate Navigation systems. With deployments exceeding 40 institutions across North America and Europe, Medivis provides essential tools for enhancing surgical planning and execution.Medivis' revenue model is based on B2B relationships with healthcare institutions. The company generates income through direct sales and partnerships, deploying products like the Medivis PRO for operating rooms and the portable Medivis CORE for ICUs and clinics. Pricing structures are tailored to each deployment, ensuring hospitals and medical schools have the necessary support and ongoing updates for their systems.In June 2023, Medivis raised USD 20 mn in Series A funding, which will be utilized to advance engineering efforts, secure regulatory clearances, and support international commercialization across various medical specialties. The company aims to release new products, including additional navigation solutions, while expanding its market presence into new regions by focusing on strategic partnerships and innovative product offerings.

## Funding rounds

- Series A, Jun 13, 2023, $20M — Mayo Clinic Ventures, Thrive Capital, Initialized Capital, Thirty5 Ventures, Coalition Operators
- Seed, Jun 15, 2020, $5M — Initialized Capital, Alumni Ventures Group, Vectr Ventures
- Seed, Feb 12, 2019, $2.3M — Initialized Capital

## Investors

- Initialized Capital (https://capitalatlas.ai/funds/initialized-capital) — Seed, Series A
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Seed
- Vectr Ventures (https://capitalatlas.ai/funds/vectr-ventures) — Seed
- Mayo Clinic Ventures (https://capitalatlas.ai/funds/mayo-clinic-ventures) — Series A
- Thrive Capital (https://capitalatlas.ai/funds/thrive-capital) — Series A
- Thirty5 Ventures (https://capitalatlas.ai/funds/thirty5-ventures) — Series A
- Coalition Operators (https://capitalatlas.ai/funds/coalition-operators) — Series A